Vaccines Market Research Reports & Industry Analysis

Vaccine stands for a preparation of dead, attenuate or else modified viruses, bacteria and other microorganisms utilized as an inoculation to immunize against any disease by way of stimulating antibodies’ production. With constant technology upgrades and launches of new medicinal products, Vaccines proved to be the most sophisticated healthcare aid ever created in the pharma’s history.

The global Vaccine Industry is thriving mainly owing to the chronic availability of different diseases, both already-existing and cropping up on the horizon, which can be luckily prevented with Vaccines’ assistance. Pediatric Vaccines form the largest and the most hastily evolving segment as against adult Vaccines, with the trend predicted to stay unaltered in the impending period. The worldwide Vaccine Market is primarily in the paws of such behemoths as Merck & Company, Inc.; Novartis, Pfizer, Inc.; GlaxoSmithKline plc; and Sanofi Pasteur.

The research reports under this Catalogue provide in-depth assessments of the global Vaccine Industry, discussing pressing market issues and statistical figures. The research reports cover the sizing (value/volume) and short-to-long-run forecasts for the overall Vaccine Market and its major segments, and for numerous geographic markets. The listing of M&As among the Vaccine universe participants with new products’ reviews, alongside company profile information can be derived from the research reports too.

Found 428 publications
Global Skin Cancer Vaccine Market & Pipeline Insight 2015 US$ 1,500.00

... Skin Cancer Vaccine Global Skin Cancer Vaccine Market Analysis Global Skin Cancer Vaccine Pipeline by Company & Phase Global Skin Cancer Vaccine Pipeline: 47 Vaccines Majority Skin Cancer Vaccines in Phase-I: 12 Vaccines Marketed Skin Cancer Vaccines ...

Feb, 2015 179 pages
Global Lung Cancer Vaccine Market & Pipeline Insight 2015 US$ 1,200.00

... Lung Cancer Vaccine Global Lung Cancer Vaccine Market Analysis Global Lung Cancer Vaccine Pipeline by Company & Phase Global Lung Cancer Vaccine Pipeline: 29 Vaccines Majority Lung Cancer Vaccines in Phase-II: 8 Vaccines Marketed Lung Cancer Vaccines: 3 ( BV NSCLC 001, Mycidac-C & Vaxira) Personalized Cancer ...

Feb, 2015 120 pages
Global Preventable Vaccines Market 2015-2019 US$ 3,000.00

... Vaccines TechNavio's report, the Global Preventable Vaccines Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from ... . The report includes a discussion of the key vendors operating in this market. Key Regions Americas APAC EMEA Key Vendors GlaxoSmithKline Merck ...

Feb, 2015 137 pages
2015 Market Research Report on Global Influenza Vaccine Industry US$ 2,600.00

'2015 Market Research Report on Global Influenza Vaccine Industry' is a professional and deep research report in this field. For overview analysis, the report ... , cost, price, profit, production value, and gross margin for these markets are also included. For technical data and manufacturing plants analysis ...

Feb, 2015 178 pages
2015 Deep Research Report on Global Vaccine Refrigerator Industry US$ 2,600.00

'2015 Deep Research Report on Global Vaccine Refrigerator Industry' is a professional and depth research report on Global and China Vaccine Refrigerator Industry. ... , and competitive landscape, and leading suppliers and countries’2010-2015 capacity, production, cost, price, profit, production value, and gross ...

Feb, 2015 183 pages
Global Swine Vaccine Industry 2014 Market Research Report US$ 2,850.00

2014 Global Swine Vaccine Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Swine ... , Germany, Japan and China). The report firstly introduced the Swine Vaccine basics: definitions, classifications, applications and industry chain overview; ...

Jan, 2015 176 pages
Research and Investment Prospect of Human Vaccine Industry in China, 2014-2018 US$ 2,000.00

Research and Investment Prospect of Human Vaccine Industry in China, 2014-2018, mainly studies the market, competition pattern and segmentations of human ... of state-owned enterprises, private enterprises and foreign-funded enterprises in China. Seeing from the lot release quantity of vaccine in 2013, the state ...

Dec, 2014 56 pages
China poultry vaccine Industry, 2015 US$ 3,600.00

... partner with one of the key Chinese corporations, to get market shares as China is boosting its domestic needs; to forecast the future of the world economy ... compete against any of the companies in this field, then China poultry vaccine industry, 2015 is required reading. This report will take 5 business days ...

Jan, 2015
Global Varicella Vaccine Industry 2014 Market Research Report US$ 2,850.00

2014 Global Varicella Vaccine Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Varicella Vaccine industry, focusing on the main regions (North America, Europe and Asia) and the main countries ( ...

Dec, 2014 176 pages
Global Hepatitis B Vaccine Industry 2014 Market Research Report US$ 2,850.00

2014 Global Hepatitis B Vaccine Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Hepatitis B Vaccine industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and ...

Dec, 2014 176 pages
Global Animal Vaccine Industry 2014 Market Research Report US$ 2,850.00

2014 Global Animal Vaccine Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Animal ... , Germany, Japan and China). The report firstly introduced the Animal Vaccine basics: definitions, classifications, applications and industry chain overview; ...

Dec, 2014 176 pages
Global Prostate Cancer Vaccine Clinical Pipeline Insight 2015 US$ 1,500.00

... body to activate the immune cells. They identify these antigens as non-self and begin to search and eliminate cancerous cells from body ... ” Report Highlights: Introduction to Prostate Cancer Vaccine Mechanism of Prostate Cancer Vaccine Global Prostate Cancer Vaccine Clinical Trial Insight by Company, Country ...

Jan, 2015 155 pages
Global Peptide Vaccine Market & Pipeline Insight US$ 1,800.00

... raw materials and have high cost-arbitrage. Over time, reduced marketing time coupled with their therapeutic property will make them ... gives an idea about optimistic future that would be achieved in coming years. “Global Peptide Vaccine Market & Pipeline Insight” Report Highlights: Introduction & Mechanism ...

Jan, 2015 200 pages
Dendritic Cell Cancer Vaccine Market & Clinical Insight US$ 1,800.00

... and elimination from the body. In 1868, Paul Langerhans discovered dendritic cells and thought that they are part of nervous system ... & Clinical Insight” Report Highlights: Introduction & Mechanism of Dendritic Cell Cancer Vaccines Dendritic Cell Vaccine Market Overview Market Dynamics (Drivers, Challenges ...

Jan, 2015 190 pages
Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325414 US$ 1,995.00

... metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. KEY FINDINGS: Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.) to reach $39.5 billion by 2021. Vaccines, Skin Replacement Products and Biologicals Manufacturing ...

Dec, 2014 65 pages
Influenza Vaccines Market & Forecast - Worldwide Analysis US$ 1,490.00

... main drivers to galvanized Influenza vaccines market. Seasonal Influenza vaccines market has Billions US$ market in 2013. Seasonal Influenza vaccines market is expected to grow ... digit percentage from 2013 to 2019. On the other hand, H1N1 Influenza vaccines market has seen tremendous growth during 2009 and ...

Nov, 2014 179 pages
Global Breast Cancer Vaccine Clinical Trial Insight US$ 1,200.00

... Breast Cancer Vaccine Clinical Trial Insight” Report Highlight: Global Breast Cancer Vaccine Market Overview Global Breast Cancer Vaccine Clinical Pipeline by ... are used to prevent cancer from developing in healthy people. With the approval of the prostate cancer vaccine, Provenge by Dendreon, the field of ...

Oct, 2014 134 pages
Global and Chinese Pandemic Influenza Vaccine Industry, 2009-2019 Market Research Report US$ 2,400.00

... capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, ... . Overall, the report provides an in-depth insight of 2009-2019 global and Chinese Pandemic Influenza Vaccine industry covering all important parameters.

Oct, 2014 150 pages
Global Pediatric Vaccine Market 2014-2018 US$ 2,500.00

... , hepatitis, pneumococcal diseases, and meningococcal diseases. According to the US FDA, pediatric age ranges are classified as newborn, infant, child, and adolescent, ... through the sales of various approved vaccines. TechNavio's report, the Global Pediatric Vaccine Market 2014-2018, has been prepared based ...

Oct, 2014 85 pages
Ebola Virus Vaccine Market & Pipeline Insight US$ 1,500.00

... has been met till now. The pharma companies have a significant opportunity in the field of Ebola virus infections in terms of developing drugs, ... return on investment. “Ebola Virus Vaccine Market & Pipeline Insight” Report Highlight: Ebola Virus Infection Market Overview Ebola Vaccine Clinical Trial ...

Oct, 2014 80 pages
Competitor Analysis: Rabies Virus Vaccines, Antibodies and Immune Globulins US$ 255.00

Competitor Analysis: Rabies Virus Vaccines, Antibodies and Immune Globulins The present Competitive Intelligence Report about prophylaxis and therapy of Rabies ... virus infections as of September 2014. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any ...

Sep, 2014 33 pages
Competitor Analysis: Ebola Virus Vaccines and Therapeutics US$ 255.00

Competitor Analysis: Ebola Virus Vaccines and Therapeutics The present Competitive Intelligence Report about prophylaxis and therapy of Ebola virus infections ... Ebola virus infections as of October 2014. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any ...

Oct, 2014 43 pages
Global Potential Analysis of Ebola drug and Vaccines Market (Pipeline analysis, Drugs, Vaccines, and Geography) through 2020 US$ 2,625.00

... drug candidate for EVD. Both these companies are developing their anti-ebola products under the contract of the U.S. department of defense (DoD). ... held in past years concerning the development of ebola viral disease therapeutics Pin-point analysis of geographic segments helps to identify opportunities for ...

Sep, 2014 55 pages
Global Cancer Vaccines Market & Pipeline Analysis US$ 2,400.00

... present day do not have effective treatments. Therapeutic cancer vaccines and Prophylactic cancer vaccines are the two broad segments into ... Pipeline by Phase, Indication, Company & Country Global Cancer Vaccine Clinical Pipeline: 289 Vaccines Marketed Cancer Vaccines: 12 Vaccines Regulatory Framework for ...

Sep, 2014 864 pages
Global Hepatitis B Vaccines Market 2014-2018 US$ 2,500.00

... transient serum sickness-like syndrome, and membranous glomerulonephritis. Perinatal transmission of hepatitis B virus is the most common mode of infection spread. Age of a person ... the present scenario and the growth prospects of the Global Hepatitis B Vaccines market for the period 2014-2018. To calculate the ...

Aug, 2014 91 pages
Global Meningococcal Vaccines Market 2014-2018 US$ 2,500.00

... to grow at a CAGR of 15.00 percent over the period 2013-2018. Covered in this Report This report covers the present scenario and the ... caused by different serogroups of Neisseria meningitides. TechNavio's report, the Global Meningococcal Vaccines Market 2014-2018, has been prepared based on an in-depth ...

Aug, 2014 78 pages
OpportunityAnalyzer: Dengue Vaccines - Opportunity Analysis and Forecasts to 2020 US$ 7,995.00

OpportunityAnalyzer: Dengue Vaccines - Opportunity Analysis and Forecasts to 2020 SUMMARY Dengue is a febrile illness caused by the dengue virus (DENV), a single-stranded ... 2015-2020. Annual cost of therapy (ACOT) and major pipeline vaccine sales in this forecast period are included. Key topics covered ...

Jul, 2014 188 pages
2014 Market Research Report on Global Encephalitis Vaccine Industry US$ 2,850.00

2014 Market Research Report on Global Encephalitis Vaccine Industry was a professional and depth research report on Global Encephalitis Vaccine industry that you ... from Encephalitis Vaccine industry chain related technical experts and marketing experts during Research Team survey and interviews. The report ...

Jun, 2014 176 pages
V503 (Prophylactic Human Papillomavirus Vaccines) - Forecast and Market Analysis to 2022 US$ 3,495.00

V503 (Prophylactic Human Papillomavirus Vaccines) - Forecast and Market Analysis to 2022 SUMMARY The first prophylactic vaccine for immunization against human ... Cervarix providing the only competition. The introduction of Merck’s nine-valent vaccine (V503) is set to change the future landscape of the HPV ...

Mar, 2014 69 pages
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - US Drug Forecast and Market Analysis to 2022 US$ 4,995.00

PharmaPoint: Prophylactic Human Papillomavirus Vaccines - US Drug Forecast and Market Analysis to 2022 SUMMARY The first prophylactic vaccine for immunization against ... sector. In the US the total number of HPV vaccine doses delivered annually is likely to grow steadily over the next few years, as more ...

Mar, 2014 94 pages
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Japan Drug Forecast and Market Analysis to 2022 US$ 4,995.00

PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Japan Drug Forecast and Market Analysis to 2022 SUMMARY The first prophylactic vaccine for immunization against ... SWOT analysis. Sales forecast for the top drugs in the Japan from 2012-2022. Analysis of the impact of key events as well the drivers ...

Mar, 2014 86 pages
PharmaPoint: Prophylactic Human PapillomaVirus Vaccines - Current and Future Players US$ 2,995.00

... SUMMARY GlobalData has released its pharma report, “PharmaPoint: Prophylactic Human PapillomaVirus Vaccines - Current and Future Players”. The report is a vital ... key companies shaping and driving the global Prophylactic Human Papillomavirus Vaccines market. The report provides insight into the competitive ...

Mar, 2014 40 pages
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Canada Drug Forecast and Market Analysis to 2022 US$ 4,995.00

PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Canada Drug Forecast and Market Analysis to 2022 SUMMARY The first prophylactic vaccine for immunization against ... as a SWOT analysis. Sales forecast for the top drugs in the Canada from 2012-2022. Analysis of the impact of key events as well the ...

Mar, 2014 94 pages
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Australia Drug Forecast and Market Analysis to 2022 US$ 4,995.00

PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Australia Drug Forecast and Market Analysis to 2022 SUMMARY The first prophylactic vaccine for immunization against ... program from 2013 will drive the expansion of the HPV vaccines market over the forecast period. GlobalData expects that following ...

Mar, 2014 91 pages
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - 5EU Drug Forecast and Market Analysis to 2022 US$ 6,995.00

PharmaPoint: Prophylactic Human Papillomavirus Vaccines - 5EU Drug Forecast and Market Analysis to 2022 SUMMARY The first prophylactic vaccine for immunization ... other countries Spain has relatively high coverage rates for HPV vaccination, which GlobalData expects will persist throughout the forecast period ...

Mar, 2014 127 pages
Gardasil (Prophylactic Human PapillomaVirus Vaccines) - Forecast and Market Analysis to 2022 US$ 3,495.00

Gardasil (Prophylactic Human PapillomaVirus Vaccines) - Forecast and Market Analysis to 2022 SUMMARY The first prophylactic vaccine for immunization against human ... as a SWOT analysis. Sales forecast for Gardasil for the top nine countries from 2012 to 2022. Sales information covered for the US, France, ...

Mar, 2014 45 pages
Cervarix (Prophylactic Human PapillomaVirus Vaccines) - Forecast and Market Analysis to 2022 US$ 3,495.00

Cervarix (Prophylactic Human PapillomaVirus Vaccines) - Forecast and Market Analysis to 2022 SUMMARY The first prophylactic vaccine for immunization against human ... as a SWOT analysis. Sales forecast for Cervarix for the top nine countries from 2012 to 2022. Sales information covered for the US, France, ...

Mar, 2014 44 pages
Human Papillomavirus Infections Vaccine Pipeline Analysis US$ 1,800.00

... could thus be used as a basis of the vaccine. There are only 2 HPV vaccines which are currently marketed across the globe. Both ... to treat it, either through drugs or through vaccines. “Human Papillomavirus Infections Vaccine Pipeline Analysis” Report Highlights: Human Papillomavirus Vaccine Market Overview ...

Jun, 2014 197 pages
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Global Drug Forecast and Market Analysis to 2022 US$ 10,995.00

... The first prophylactic vaccine for immunization against human papillomavirus (HPV) became available in 2006. The global HPV vaccines market is now ... access. Identify opportunities for the development and delivery of HPV vaccines, and to identify emerging players with potentially strong product portfolios. ...

Mar, 2014 188 pages
Global Vaccine Market Outlook 2020 US$ 1,500.00

... activities and generic competition for off patent products. On the contrary, vaccine segment has developed as highly profitable because of advancements in genomics and ... sales, which thereby allure the market players. The report, “Global Vaccine Market Outlook 2020” provides an extensive research and in-depth ...

May, 2014 135 pages
Global Influenza (Flu) Vaccine Market: Trends & Opportunities (2014-19) US$ 800.00

Scope of the Report The report titled “Global Influenza (Flu) Vaccine Market: Trends and Opportunities (2014-2019)” provides an insight into the ... Abbott Laboratories, Novartis, CSL and Glaxo Smith Kline. Geographical Coverage Global United States Japan Germany United Kingdom Company Coverage Sanofi ...

Apr, 2014 60 pages
PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Current and Future Players US$ 2,995.00

Summary GlobalData has released its pharma report, “PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Current and Future Players”. The report is a vital ... with in-depth analysis on the companies in the rapidly growing Prophylactic hepatitis B virus vaccines Market. The report identifies and analyses the ...

Jan, 2014 70 pages
Vaccine Development Strategies - Refocusing Efforts to Address New Challenges US$ 3,900.00 US$ 3,510.00

... , including recent activities of major pharmaceutical companies, insight into the challenges being faced by companies developing therapeutic vaccines and recommendations on clinical development strategies to overcome these potential obstacles and hurdles The report assesses the evolving competitive vaccines ...

Feb, 2014 60 pages
Twinrix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 US$ 3,495.00

Twinrix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people ...

Jan, 2014 67 pages
Recombivax HB (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 US$ 3,495.00

Recombivax HB (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion ...

Jan, 2014 68 pages
Pediarix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 US$ 3,495.00

Pediarix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people ...

Jan, 2014 65 pages
Infanrix Hexa (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 US$ 3,495.00

Infanrix Hexa (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is ... well as a SWOT analysis. Sales forecast for Infanrix Hexa for top six countries from 2012 to 2022. Sales information covered for the US, ...

Jan, 2014 65 pages
Hexyon (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 US$ 3,495.00

Hexyon (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people are ...

Jan, 2014 66 pages
Heplisav (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 US$ 3,495.00

Heplisav (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people ...

Jan, 2014 91 pages
Fendrix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 US$ 3,495.00

Fendrix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people ...

Jan, 2014 64 pages
1 2 3 4 5 >
Skip to top